← SynDRA
DELAFLOXACIN
SynDRA canonical compound SYN0031514 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Approval status | Approved · Rx |
| Mechanism of action | antiinfective drug |
All known targets
- Malaria gyrase
- Stap-coc parC
Mechanisms of action (all sources)
- antiinfective drug
- Modulator
- Inhibitor
Drug classes
- Anti-Infective Agents
- Fluoroquinolone Antibacterial
ATC classes
- J01M · QUINOLONE ANTIBACTERIALS
Cross-references
Synonyms
- delafloxacin meglumine
- baxdela
- RX-3341
- WQ-3034
- ABT-492
- Delafloxacine
- Delafloxacino
- Delafloxacin Meglumine
- Baxdela
- Abt 492
- 1-(6-AMINO-3,5-DIFLUOROPYRIDIN-2-YL)-8-CHLORO-6-FLUORO-7-(3-HYDROXYAZETIDIN-1-YL)-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
- ABT492
- UNII-6315412YVF
- 6315412YVF
- 1-(6-amino-3,5-difluoro-2-pyridyl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-quinoline-3-carboxylic acid
- 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxoquinoline-3-carboxylic acid
- Delafloxacin [USAN:INN]
- Delafloxacinum
- Delafloxacin (USAN)
- WQ 3034
- delafloxacine
- delafloxacino
- RefChem:57796
- DTXCID9094822
- J01MA23
- Delafloxacin [USAN]
- MFCD09955301
- Quofenix
- C18H12ClF3N4O4
- TE9
- Abbott 492
- Delafloxacin (Standard)
- DelafloxacinABT-492?
- Delafloxacin 100 microg/mL in Acetonitrile
- DELAFLOXACIN [MI]
- Delafloxacin Impurity 48
- DELAFLOXACIN [INN]
- DELAFLOXACIN [WHO-DD]
Reported adverse events
- Tendinitis
- Peripheral neuropathy
- Headache
- Hypersensitivity
- Nausea
- Vomiting
- Clostridium difficile infection
Look up DELAFLOXACIN in the interactive SynDRA portal →